-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Raphael Pharmaceutical Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
- Raphael Pharmaceutical Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$319K, a 56.2% increase year-over-year.
- Raphael Pharmaceutical Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$981K, a 60.9% increase year-over-year.
- Raphael Pharmaceutical Inc. annual Operating Income (Loss) for 2023 was -$1.27M, a 61.7% increase from 2022.
- Raphael Pharmaceutical Inc. annual Operating Income (Loss) for 2022 was -$3.32M, a 104% decline from 2021.
- Raphael Pharmaceutical Inc. annual Operating Income (Loss) for 2021 was -$1.63M, a 131% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)